Numinus WellnessNUMIF -25.77% 9-Day RSI is 45.16 as of Jun. 27, 2026. Among 702 Healthcare Providers & Services companies, Numinus Wellness ranks better than 63.53% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-06-27), Numinus Wellness's 9-Day RSI is 45.16.
The industry rank for Numinus Wellness's 9-Day RSI or its related term are showing as below:
NUMIF's 9-Day RSI is ranked better than 63.53% of 702
companies
in the Healthcare Providers & Services industry
Industry Median: 46.32
vs NUMIF: 45.16
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Numinus Wellness 9-Day RSI Related Terms
NUMIF vs HLYK, SYRA, GBCS: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Numinus Wellness's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numinus Wellness 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Numinus Wellness's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numinus Wellness (NUMIF) has a 9-Day RSI of 45.16 as of Jun. 27, 2026. According to the industry distribution chart, Numinus Wellness ranks #256 out of 702 companies in the Healthcare Providers & Services industry, placing it in the top 36.5%.
Is Numinus Wellness' 9-Day RSI too high?
Numinus Wellness' current 9-Day RSI is 45.16. The Healthcare Providers & Services industry median 9-Day RSI is 46.32. Numinus Wellness' value of 45.16 is 2.5% below this industry median. Based on the distribution chart, Numinus Wellness ranks #256 out of 702 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Numinus Wellness' 9-Day RSI compare to HLYK and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Numinus Wellness ranks #256 out of 702 companies for 9-Day RSI. This puts Numinus Wellness in the upper half of its industry. The industry median 9-Day RSI is 46.32. Numinus Wellness' value of 45.16 is 2.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 46.32, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Numinus Wellness's current 9-Day RSI of 45.16 is 2.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 46.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current 9-Day RSI is 45.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current 9-Day RSI of 45.16. The current 9-Day RSI is 45.16 and 2.5% below the Healthcare Providers & Services industry median of 46.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current 9-Day RSI is 45.16 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUMIF has been successfully added to your